D63.0

Clinical Causes: Cancer itself can interfere with red blood cell production, especially if it affects the bone marrow where blood cells are made. Certain cancer treatments such as chemotherapy and radiation can damage healthy blood-producing cells, leading to anemia. Nutritional deficiencies, common in cancer patients, such as iron, vitamin B12, or folate deficiency, can contribute to anemia. Chronic blood loss, which may occur due to tumors in the gastrointestinal tract or other sites, can lead to reduced red blood cell levels. Immune system responses in some cancer patients can cause the premature destruction of red blood cells, resulting in anemia.

Key Symptoms: Fatigue and weakness Shortness of breath during activity or at rest Paleness of the skin and mucous membranes Rapid or irregular heartbeat Dizziness or lightheadedness Cold hands and feet Headaches Difficulty concentrating

Diagnosis Path: Diagnosing anemia in individuals with neoplastic disease involves blood tests that measure hemoglobin levels and red blood cell counts. Additional tests may include iron studies, vitamin B12 and folate levels, and a reticulocyte count to evaluate bone marrow function. In some cases, a bone marrow biopsy is performed to assess the marrow’s ability to produce blood cells and to identify infiltration by cancer cells or other abnormalities. Imaging studies may also be used to determine if the cancer has spread to bones or other organs that could affect blood cell production.

Treatment Protocols: Management of anemia in patients with neoplastic disease depends on the underlying cause and severity. Typical approaches include: - Blood transfusions to quickly increase red blood cell levels in severe cases. - Treatment of the underlying cancer, which may improve anemia symptoms. - Dietary supplements such as iron, vitamin B12, or folic acid if deficiencies are identified. - Erythropoiesis-stimulating agents (ESAs) to stimulate red blood cell production, used cautiously under medical supervision. - Adjustments in cancer treatment regimens to minimize impact on blood cell production. It is important for healthcare providers to regularly monitor blood counts and tailor treatment plans accordingly to improve symptoms and maintain overall health during cancer therapy.